Table 2 Cardiovascular risk factors associated with changes in LAP Index
From: Importance of lipid accumulation product index as a marker of CVD risk in PCOS women
Variable | LAPa | p – value* | |
|---|---|---|---|
≥37.9 cm.mmol/L | <37.9 cm.mmol/L | ||
(n = 32) | (n = 46) | ||
BMIb, n (%) | <0.001 | ||
Not obese | 23 (85.2) | 4 (14.8) | |
Obese | 9 (17.7) | 42 (82.3) | |
WCc, n (%) | <0.001 | ||
High | 30 (78.9) | 8 (21.1) | |
Normal | 2 (5.0) | 38 (95.0) | |
Fasting glucose, n (%) | 0.028 | ||
High | 5 (83.3) | 1 (16.7) | |
Normal | 27 (37.5) | 45 (62.5) | |
Total cholesterol, n (%) | 0.005 | ||
High | 14 (66.7) | 7 (33.3) | |
Normal | 18 (31.6) | 39 (68.4) | |
Triglycerides, n (%) | <0.001 | ||
High | 16 (94.1 | 1 (5.9) | |
Normal | 16 (26.2) | 45 (73.8) | |
LDL-cd, n (%) | 0.005 | ||
High | 11 (73.3) | 4 (26.7) | |
Normal | 21 (33.3) | 42 (66.7) | |
HDL-ce, n (%) | <0.001 | ||
Normal | 20 (31.3) | 44 (68.8) | |
Low | 12 (85.7) | 2 (14.3) | |
SBPf (mmHg) | <0.001 | ||
Normotensive | 6 (17.1) | 29 (82.9) | |
Not normotensive | 26 (60.5) | 17 (39.5) | |
DBPg (mmHg) | <0.001 | ||
Normotensive | 7 (17.1) | 34 (82.9) | |
Not normotensive | 25 (67.6) | 12 (32.4) | |